The US Life Sciences compensation landscape: what disclosed ranges actually reveal
Pay-transparency laws are pulling the curtain back on Life Sciences compensation across the US. Here is what disclosed ranges tell us - and what they leave out.
Compensation conversations in Life Sciences have historically been conducted in whispers - mediated by recruiters, benchmarked by survey firms, and disclosed to candidates only at the offer stage. Pay-transparency legislation in Colorado, New York, California, Washington, and a growing list of states is changing that. For the first time, a substantial volume of public postings includes salary ranges.
What transparency does and does not reveal
A disclosed range on a posting tells you the floor and ceiling for that role as the employer defines it. It does not tell you where within that band a given candidate will land, how the bonus target is structured, or whether equity is part of the package. Wide bands - common in pharma - can span a gap large enough to make the disclosure nearly meaningless in isolation.
A disclosed range is not a compensation strategy. It is a starting point for one - and it is more than candidates had before.
How a scout turns disclosure into signal
When a daily scout captures disclosed ranges across thousands of postings, patterns emerge that no single posting reveals. Bands cluster by function, geography, and company stage. A candidate preparing for a conversation can see not just what one employer posted, but how that range sits relative to the market - whether it is at the floor, the ceiling, or somewhere defensible in between.
We surface these patterns through the weekly issue of The Meridian, grounded in aggregate data from our matching corpus. Every figure we publish traces to a minimum sample of disclosed postings, rounded and anonymized, so no single employer or candidate is ever identifiable.